Article Versions Notes

Sabrina S, Takeda Y, Kato T, Naito S, Ito H, Takai Y, Ushijima M, Narisawa T, Kanno H, Sakurai T, et al. Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma. Biomedicines. 2023; 11(5):1296. https://doi.org/10.3390/biomedicines11051296

Sabrina, Saima, Yuji Takeda, Tomoyuki Kato, Sei Naito, Hiromi Ito, Yuki Takai, Masaki Ushijima, Takafumi Narisawa, Hidenori Kanno, Toshihiko Sakurai, and et al. 2023. "Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma" Biomedicines 11, no. 5: 1296. https://doi.org/10.3390/biomedicines11051296

Sabrina, S., Takeda, Y., Kato, T., Naito, S., Ito, H., Takai, Y., Ushijima, M., Narisawa, T., Kanno, H., Sakurai, T., Saitoh, S., Araki, A., Tsuchiya, N., & Asao, H. (2023). Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma. Biomedicines, 11(5), 1296. https://doi.org/10.3390/biomedicines11051296